2025年A股1442家公司预亏，行业“亏损王”浮出

Core Viewpoint - In the 2025 annual performance forecast disclosure for A-share listed companies, nearly half of the 2957 companies are expected to report losses, indicating a significant downturn in various sectors, particularly in real estate [5][6]. Group 1: Overall Performance Forecast - A total of 2957 A-share listed companies disclosed their performance forecasts, with 623 companies expecting profit increases and 378 expecting profit decreases [5][6]. - Among the companies, 1442 are expected to incur losses, accounting for 49% of those disclosing forecasts, while 1863 companies (63%) are either expecting losses or profit reductions [6]. - The provinces with the highest number of companies forecasting losses include Guangdong (257), Beijing (172), and Jiangsu (160) [7]. Group 2: Provincial Distribution of Losses - Hainan province has the highest loss ratio, with 44.44% of its companies (12 out of 27) expecting losses [9]. - Jilin and Qinghai follow with loss ratios of 41.67% and 40%, respectively [9]. - Other provinces with significant loss ratios include Liaoning (39.29%) and Xinjiang (37.10%) [9]. Group 3: Industry-Specific Losses - The IT services and software development sectors have the highest number of companies forecasting losses, with 60 companies each, followed by the real estate sector with 54 companies [11]. - Vanke A is identified as the "loss king" of A-shares, expecting a net profit loss of approximately 82 billion yuan due to declining project settlement scales and increased business risks [11][12]. - Other notable companies with high expected losses include China Fortune Land Development (160-240 billion yuan) and Greenland Holdings (160-190 billion yuan), both from the real estate sector [12]. Group 4: Notable Losses in Other Sectors - The retail sector's "loss king" is Meikailong, expecting a net profit loss between 150 billion and 225 billion yuan, primarily due to losses in investment properties [13]. - In the home appliance sector, Shenkangjia A anticipates a loss of 125.81 billion to 155.73 billion yuan, driven by increased impairment provisions and declining sales [13]. - The vaccine industry is also facing challenges, with Zhifei Biological Products forecasting a loss of 106.98 billion to 137.26 billion yuan due to decreased public willingness to receive vaccinations [13].